BDBM532435 US11214548, Compound 368

SMILES CC(C)[C@@]12C[C@@H]1[C@@H](C)c1c2c(nn1-c1ccc(F)cc1F)C(=O)N[C@@H]1[C@@H](O)Cc2ccccc12

InChI Key InChIKey=UNDADZALONRRPE-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 532435   

TargetCannabinoid receptor 1(Human)
Arena Pharmaceuticals

US Patent
LigandPNGBDBM532435(US11214548, Compound 368)
Affinity DataEC50:  35nMAssay Description:Table D: Radioligand binding assays for human CB2 receptors were performed using two different agonist radioligands, [3H]CP55,940 and [3H]WIN55,212-2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Arena Pharmaceuticals

US Patent
LigandPNGBDBM532435(US11214548, Compound 368)
Affinity DataEC50:  354nMAssay Description:Table B: HTRF assay was carried out using a two-step protocol essentially according to the kit manufacturer's instructions, in 20 μL total v...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent